Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Colonic Polyps 2 Breast Neoplasms 2 Rectal Diseases 1 Prostatic Neoplasms 1 Pneumoperitoneum 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Lung Cancer Metastatic 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Gastric Subepithelial Tumor 1 Erectile Dysfunction 1 Endometriosis 1 Diverticulitis 1 Crohn Disease 1 Constipation 1 Colorectal Neoplasms 1 Colonic Diseases 1 Colitis, Ulcerative 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bites and Stings 1 Bile Duct Neoplasms 1 Agnosia 1

Interventions

tremelimumab 1 regramostim 1 osimertinib 1 evolocumab 1 durvalumab 1 Surgical Instruments 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Needles 1 MLN 8237 1 Ipilimumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Cancer Metastatic × Surgical Instruments × Clear all

NCT05706883 2024-04-05

ProphetaPro

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡